PINK:GTHP

Guided Therapeutics Stock Forecast

etoro logo Buy GTHP
*Your capital is at risk
$0.228
+0 (+0%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of GTHP AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GTHP to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Guided Therapeutics, Inc.
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 02, 2026

No changes to the price of Guided Therapeutics, Inc. stock on the last trading day (Friday, 5th Jun 2026). During the last trading day the stock fluctuated 0% from a day low at $0.228 to a day high of $0.228. The price has been going up and down for this period, and there has been a 14% gain for the last 2 weeks.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.229 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -22.61% during the next 3 months and, with a 90% probability hold a price between $0.114 and $0.177 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GTHP Signals & Forecast

The Guided Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.225 and $0.209. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Monday, April 13, 2026 and based on theory for this formation the price should go up by 15.37% to $0.263 within 5 trading days (Monday, April 20, 2026) since signal was issued.

Support, Risk & Stop-loss for Guided Therapeutics, Inc. stock

Guided Therapeutics, Inc. finds support from accumulated volume at $0.220 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $0.219 (-3.82%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (GTHP) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Guided Therapeutics, Inc. to open at $0.228, and during the day (based on 14 day Average True Range), to move between $0.220 and $0.236, which gives a possible trading interval of +/-$0.0168 (+/-7.66%) up or down from last closing price. If Guided Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.66% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.230 (0.88%) than the support at $0.220 (3.51%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Guided Therapeutics, Inc. stock A Buy?

Guided Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.228 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GTHP Performance

Trading levels for GTHP

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.228 -
R2 0.228 -
R1 0.228 -
Price 0.228
S1 0.228 -
S2 0.228 -
S3 0.228 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.250 9.65%
R2 0.240 5.18%
R1 0.230 0.88%
Price 0.228
S1 0.220 -3.51%
S2 0.200 -12.28%
S3 0.190 -16.67%

FAQ

What is the symbol for Guided Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Guided Therapeutics, Inc. is GTHP and it is traded on the PINK (Pink Sheets).

Should I buy or sell Guided Therapeutics, Inc. Stock?
Guided Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Guided Therapeutics, Inc. Stock?
Guided Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Guided Therapeutics, Inc. Stock.

What's the current price of Guided Therapeutics, Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Guided Therapeutics, Inc. (GTHP) share was $0.228.

What is the 52-week high and low for Guided Therapeutics, Inc. Stock?
The 52-week high for Guided Therapeutics, Inc. Stock is $0.540 and the 52-week low is $0.123.

What is the market capitalization of Guided Therapeutics, Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Guided Therapeutics, Inc. is 17.488M.
Click to get the best stock tips daily for free!
ABOUT GUIDED THERAPEUTICS, INC.
Guided Therapeutics
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its n...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
SAP
$172.39
7.18% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE